Longevity Health Holdings (XAGE) has a profit margin of -380.73%, below the sector sector average of 19.61%.
Get informed when a big investor buys or sells
+ FollowAs of Mar 2026
Trailing 12 months ending Mar 2026
Longevity Health Holdings (XAGE) currently reports a profit margin of -380.73% as of March 2026. That compares with -53.43% in the prior-year period — down 612.6% year over year. That is below the sector sector average of 19.61%. Use the charts on this page to explore Longevity Health Holdings's profit margin history and peer comparisons.
Longevity Health Holdings's profit margin decreased from -53.43% to -380.73% — a 612.6% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Longevity Health Holdings's profit margin of -380.73% is lower than the its sector sector average of 19.61%. That is roughly 2041.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Longevity Health Holdings's current -380.73% should be judged against industry norms (sector average: 19.61%) and against XAGE's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -380.73%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 19.61%. From there, open related valuation or income-statement pages for Longevity Health Holdings, and consider following XAGE for alerts when major investors trade the stock.